Fig. 1From: Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcomaThe maximum percentage diameter changes from baseline in target lesion. The effectiveness was evaluated according to the Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST). PFS the progression-free survival, UPS undifferentiated pleomorphic sarcoma, PNET primitive neuroectodermal tumorBack to article page